Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Schoeberl

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Science Signaling|December 24, 2015
Beyond static biomarkers--The dynamic response potential of signaling networks as an alternate biomarker?Jaeyeon Kim, Birgit Schoeberl
Molecular Biology of the Cell|November 1, 2012
An expanding role for cell biologists in drug discovery and pharmacologyPeter K Sorger, Birgit Schoeberl
Handbook of Experimental Pharmacology|January 15, 2025
Future Directions for Quantitative Systems PharmacologyBirgit Schoeberl, Cynthia J Musante, Saroja Ramanujan
Biophysical Journal|May 29, 2007
Competing docking interactions can bring about bistability in the MAPK cascadeStefan Legewie, Birgit Schoeberl, Nils Blüthgen, et al.
Nature Biotechnology|March 30, 2002
Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptorsBirgit Schoeberl, Claudia Eichler-Jonsson, Ernst Dieter Gilles, et al.
Nature Chemical Biology|August 22, 2006
Systems biology and combination therapy in the quest for clinical efficacyJonathan B Fitzgerald, Birgit Schoeberl, Ulrik B Nielsen, et al.
Journal of the Royal Society, Interface|April 9, 2019
Tensor clustering with algebraic constraints gives interpretable groups of crosstalk mechanisms in breast cancerAnna Seigal, Mariano Beguerisse-Díaz, Birgit Schoeberl, et al.
International Journal of Molecular Sciences|February 25, 2023
Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African AllelesChiratidzo R Chamboko, Wayde Veldman, Rolland Bantar Tata, et al.
Tropical Medicine and Health|August 26, 2025
Physiologically based pharmacokinetic modelling to predict artemether and lumefantrine exposure in neonates weighing less than 5 kg treated with artemether-lumefantrine to supplement the clinical data from the CALINA studyHelen Gu, Nada Abla, Vinay Kumar Venishetty, et al.
Cell Communication and Signaling : CCS|June 3, 2014
Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profilesJitendra Kanodia, Diana Chai, Jannik Vollmer, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Science Signaling|December 24, 2015
Beyond static biomarkers--The dynamic response potential of signaling networks as an alternate biomarker?Jaeyeon Kim, Birgit Schoeberl
Molecular Biology of the Cell|November 1, 2012
An expanding role for cell biologists in drug discovery and pharmacologyPeter K Sorger, Birgit Schoeberl
Handbook of Experimental Pharmacology|January 15, 2025
Future Directions for Quantitative Systems PharmacologyBirgit Schoeberl, Cynthia J Musante, Saroja Ramanujan
Biophysical Journal|May 29, 2007
Competing docking interactions can bring about bistability in the MAPK cascadeStefan Legewie, Birgit Schoeberl, Nils Blüthgen, et al.
Nature Biotechnology|March 30, 2002
Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptorsBirgit Schoeberl, Claudia Eichler-Jonsson, Ernst Dieter Gilles, et al.
Nature Chemical Biology|August 22, 2006
Systems biology and combination therapy in the quest for clinical efficacyJonathan B Fitzgerald, Birgit Schoeberl, Ulrik B Nielsen, et al.
Journal of the Royal Society, Interface|April 9, 2019
Tensor clustering with algebraic constraints gives interpretable groups of crosstalk mechanisms in breast cancerAnna Seigal, Mariano Beguerisse-Díaz, Birgit Schoeberl, et al.
International Journal of Molecular Sciences|February 25, 2023
Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African AllelesChiratidzo R Chamboko, Wayde Veldman, Rolland Bantar Tata, et al.
Tropical Medicine and Health|August 26, 2025
Physiologically based pharmacokinetic modelling to predict artemether and lumefantrine exposure in neonates weighing less than 5 kg treated with artemether-lumefantrine to supplement the clinical data from the CALINA studyHelen Gu, Nada Abla, Vinay Kumar Venishetty, et al.
Cell Communication and Signaling : CCS|June 3, 2014
Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profilesJitendra Kanodia, Diana Chai, Jannik Vollmer, et al.
Pageof 4